Weight-loss Drugmaker Novo Nordisk Invests $1.2 Bn In New Factory In Denmark
Danish pharmaceutical giant Novo Nordisk, maker of diabetes and weight-loss treatments Ozempic and Wegovy, said Monday it was investing 8.5 billion kroner ($1.2 billion) to build a new factory in Denmark to produce drugs against rare diseases.
Denmark’s biggest pension fund, ATP, is taking a major hit on its 2.3 billion-krone ($324 million) stake in troubled battery ...
With experience in the bar and restaurant industry, Jack St. Peter serves as onsite manager of Rookies Bar and Grill in ...
New nonstop routes from the U.S. to Copenhagen mean Denmark is within easier reach than ever before for Scandinavian American ...
Old rivals Germany, Denmark and Sweden are together in UEFA Women's EURO 2025 Group C along with final tournament debutants ...
New health technology assessment (HTA) statistics produced by Denmark’s Medicine Council (Medicinrådet) for 2024 have ...
The coming year brings both good and bad for homeowners in Denmark. While valuations are now back at peak levels, mortgage ...
Scotland will begin their World Cup 2026 qualifying campaign away to either Denmark or Portugal on 5 September. The final ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback